You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hyperlipoproteinemia Type II

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Homozygous Familial Hypercholesterolemia Trial in Beijing (IBI306)

Active, not recruiting
  • Homozygous Familial Hypercholesterolemia
  • IBI306
  • Beijing, China
    Beijing Anzhen Hospital, Capital Medical University
Sep 12, 2022

Familial Hypercholesterolemia Trial in Amsterdam (Coronary computed tomography angiography (CCTA))

Recruiting
  • Familial Hypercholesterolemia
  • Coronary computed tomography angiography (CCTA)
  • Amsterdam, Netherlands
    Amsterdam UMC, location AMC
Apr 27, 2022

Dyslipidemias, Hypercholesterolemia, Familial Hypercholesterolemia Trial (combination product, drug, other)

Not yet recruiting
  • Dyslipidemias
  • +4 more
  • Combination Therapy
  • +5 more
  • (no location specified)
Aug 22, 2023

National Screening for Familial Hypercholesterolemia

Enrolling by invitation
  • Familial Hypercholesterolemia
    • Luxembourg, Luxembourg
      CHde Luxembourg
    Mar 4, 2022

    The Rogosin Institute Homozygous Familial Hypercholesterolemia

    Recruiting
    • Homozygous Familial Hypercholesterolemia
      • New York, New York
        The Rogosin Institute, Weill Cornell Medical College
      Feb 28, 2022

      Vytorin Reexamination Study (0653A-174)

      Completed
      Has Results
      • Primary Hypercholesterolemia and Homozygous Familial Hypercholesterolemia (HoFH)
        • (no location specified)
        Feb 7, 2022

        Heterozygous Familial Hypercholesterolemia, Atherosclerotic Cardiovascular Disease, Hypercholesterolemia Trial in Auckland,

        Recruiting
        • Heterozygous Familial Hypercholesterolemia
        • +2 more
        • Auckland, New Zealand
        • +1 more
        Aug 4, 2022

        Ezetimibe onSelect Population of Filipinos With

        Completed
        Has Results
        • Primary Hypercholesterolemia
        • Homozygous Familial Hypercholesterolemia
        • (no location specified)
        Feb 7, 2022

        LDL Hyperlipoproteinemia, Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia, Triglyceride Storage Type I or II Disease

        Not yet recruiting
        • LDL Hyperlipoproteinemia
        • +2 more
        • omega-3 fatty acids
        • Placebo
        • Novosibirsk, Novosibisk Region, Russian Federation
          Center of New Medical Technologies
        Nov 30, 2023

        Homozygous Familial Hypercholesterolemia Trial in Netherlands, South Africa, United States (Demographics, diagnosis type,

        Recruiting
        • Homozygous Familial Hypercholesterolemia
        • Demographics, diagnosis type, genotype, lipid profile, treatment allocation, country of residence.
        • Philadelphia, Pennsylvania
        • +3 more
        Sep 28, 2022

        Diet Quality and Coronary Artery Calcification in Heterozygous

        Recruiting
        • Hypercholesterolemia, Familial
        • +2 more
        • Diet
        • Québec, Canada
          Institute of nutrition and functional foods, Laval University
        Apr 22, 2022

        Familial Hypercholesterolemia Trial (familial hypercholesterolemia)

        Not yet recruiting
        • Familial Hypercholesterolemia
        • familial hypercholesterolemia
        • (no location specified)
        Sep 16, 2021

        Hypercholesterolemia, Familial, Dyslipidemias, Cardiovascular Diseases Trial in Rostock, Dresden (Lipoprotein Apheresis MONET

        Completed
        • Hypercholesterolemia, Familial
        • +2 more
        • Lipoprotein Apheresis MONET and DALI
        • Lipoprotein Apheresis DIAMED and DALI
        • Rostock, Mecklenburg-Vorpommern, Germany
        • +1 more
        Jul 27, 2022

        Heterozygous Familial Hypercholesterolemia Trial in Beijing (Ongericimab, Placebo)

        Recruiting
        • Heterozygous Familial Hypercholesterolemia
        • Ongericimab
        • Placebo
        • Beijing, Beijing, China
          Beijing Anzhen Hospital Capital Medical University City:Beijing
        Apr 12, 2022

        Hypercholesterolemia, Hypercholesterolemia, Familial, Hypercholesteremia in Children Trial in Danville (Best Practice Alert,

        Completed
        Has Results
        • Hypercholesterolemia
        • +3 more
        • Best Practice Alert
        • Health Maintenance Topic
        • Danville, Pennsylvania
          Geisinger Health System
        Jan 7, 2022

        Atherosclerosis, Hypercholesterolemia, Hyperlipoproteinemia Type II Trial (ezetimibe (plus simvastatin), (plus simvastatin))

        Completed
        • Atherosclerosis
        • +2 more
        • ezetimibe (plus simvastatin)
        • placebo (plus simvastatin)
        • (no location specified)
        Feb 7, 2022

        Hypercholesterolemia, Familial, Hypercholesterolemia, Familial, 1, Hypercholesterolemia, Familial, 2 Trial in Moscow (genetic,

        Recruiting
        • Hypercholesterolemia, Familial
        • +25 more
        • Genetic Testing
        • +7 more
        • Moscow, Russian Federation
          National Medical Research Centre for Therapy and Preventive Medi
        Jul 25, 2022

        Familial Hypercholesterolemia, Familial Hypercholesterolemia Due to Genetic Defect of Apolipoprotein B, Familial

        Recruiting
        • Familial Hypercholesterolemia
        • +7 more
        • Research-based genetic test for Familial Hypercholesterolemia
        • Vancouver, British Columbia, Canada
        • +1 more
        Jan 31, 2022

        Hypercholesterolemia, Familial, Clinical Decision Support Trial (Clinical decision support)

        Not yet recruiting
        • Hypercholesterolemia, Familial
        • Clinical Decision Support
        • Clinical decision support
        • (no location specified)
        Aug 26, 2021

        Hypercholesterolemia, Familial Hypercholesterolemia Trial (Ezetimibe, Rosuvastatin)

        Completed
        Has Results
        • Hypercholesterolemia
        • Familial Hypercholesterolemia
        • (no location specified)
        Feb 7, 2022

        Familial Hypercholesterolemia Trial in London

        Recruiting
        • Familial Hypercholesterolemia
          • London, United Kingdom
            School of Public Health, Imperial College London
          Aug 25, 2021

          Homozygous Familial Hypercholesterolemia Trial in Worldwide (Evinacumab)

          Active, not recruiting
          • Homozygous Familial Hypercholesterolemia
          • Wilmington, Delaware
          • +10 more
          Jan 30, 2023

          The Spanish Familial Hypercholesterolaemia Cohort Study

          Recruiting
          • Familial Hypercholesterolaemia
            • Madrid, Spain
              Fundacion Hipercolesterolemia Familiar
            Nov 8, 2021

            Type 1 Diabetes and Familial Hypercholesterolemia in Lower

            Completed
            • Type 1 Diabetes
            • Familial Hypercholesterolemia
              • (no location specified)
              Jun 15, 2021

              Familial Hypercholesterolemia - Heterozygous Trial in Paris (CAC Score)

              Completed
              • Familial Hypercholesterolemia - Heterozygous
              • CAC Score
              • Paris, France
                Hôpital Pitié-Salpêtrière
              Sep 9, 2021